1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Hyperoxaluria: new trials by email Literature Review of Hyperoxaluria trials Research Report on Hyperoxaluria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Novel Approach for Reducing Hyperoxaluria and Kidney Stone Risk. Tenapanor, Placebo - Hyperoxaluria | Phase 4 | Completed | University of Texas Southwestern Medical Center | 18 | 2024-07-01 | 2026-10-07 |
| Dapagliflozin and Hydrochlorothiazide in Recurring Kidney Stone Patients Dapagliflozin, Hydrochlorothiazide - Urolithiasis, Hyperoxaluria | Phase 4 | Unknown | Medical University of Vienna | 32 | 2024-03-04 | 2023-10-23 |
Urolithiasis (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2)
Hydrochlorothiazide (1) · dapagliflozin (1) · tenapanor (1)
Medical University of Vienna (1) · University of Texas Southwestern Medical Center (1)
Austria (1) · United States (1)
Jonathan M Whittamore, Ph.D. (1)
1UL1TR003163 (1)